Paul Saultier, MD, PhD

Pediatric hematologist | Associate Professor @univamu and @aphm_actu
#PHOdocs #pediatrics #hematology #oncology #immunology #pedonc #pedcsm #childhoodcancer

[Paul Saultier, MD, PhD @psaultier]

@sophie_susen @CRPP12 Un grand merci pour ta présence et l’élan donné à de nombreux projets !

[Paul Saultier, MD, PhD @psaultier]

@Mickael_Bob @reseau_c2vn @univamu @CoRaKiD_Inserm @aphm_actu @sophieliabeuf @SBurtey @PGalichon @com_SFNDT Bien joué 👏🎉

[Paul Saultier, MD, PhD @psaultier]

@nihardesai7 @NicoGagelmann @anujtiwari11 @BrownHospMed @MedTweetorials @pankti4299 @PanktiMehta24 @Torsadepointles Don't look at the smear, transfuse the patient :-)

[Centre de Référence des Pathologies Plaquettaires @CRPP12]

Le @CRPP12 et l'@AFH_Officiel organisent le 1er weekend d'éducation thérapeutique du patient 100% pathologies plaquettaires!
📍Strasbourg
📅19 et 20 novembre 2022.
Pour vous inscrire: https://t.co/QocCFVpPvl
Plus d'infos: https://t.co/unZ6blh05B et https://t.co/JyWB4oFRbC

[Paul Saultier, MD, PhD @psaultier]

@acweyand Agreed. Fibrinogen is, however, a key parameter for deciding intervention, don't you think?

[Paul Saultier, MD, PhD @psaultier]

@GraceMThomas2 @GaiaZirka @julia_tilburg @TromboseLeiden @LentingPeter @morange_pierre @reseau_c2vn @univamu Wonderful one, you have my vote ! ;-)

[Paul Saultier, MD, PhD @psaultier]

@StephaneMancini All the best Stephane !

[Paul Saultier, MD, PhD @psaultier]

@TheKidsCancerPT @aphm_actu @univamu Thanks Dan :-)

[Paul Saultier, MD, PhD @psaultier]

Our group @aphm_actu and @univamu published a randomized trial of a physical activity program for children with cancer. Benefits : exercise capacity, self-esteem, quality of life.
🙏 share and help children and adolescents with cancer #keepmoving.
#Sport #ChildhoodCancer #QoL

[Paul Saultier, MD, PhD @psaultier]

@ecancer @S_a_l_V @SIOPEurope @WorldSIOP @OncoAlert

[Paul Saultier, MD, PhD @psaultier]

https://t.co/KlDfzzmEGi

[Paul Saultier, MD, PhD @psaultier]

@WorldSIOP @ecancer @univamu @aphm_actu @S_a_l_V @valletclothilde @SIOPEurope Thank you @WorldSIOP for sharing !
We're grateful to @S_a_l_V for providing the children with cancer treated at @aphm_actu such a great support, including a gym in the ward. Hopefully, access to adapted physical activity for children with cancer will keep growing worldwide.

[Nicolas Duployez @NicolasDuployez]

Proud to share our work on #PAX5 #germline mutations 🧬and susceptibility to acute lymphoblastic #leukemia🔬
@BloodJournal https://t.co/mODt0HorMI
👉A collaborative work @CHU_Lille @univ_lille @Canther_Lille @crctoncopole w/ Laura Jamrog, Claude Preudhomme & Cyril Broccardo

[Chiara F Magnani @ChiaraFMagnani]

Our study is finally published in @jclinicalinvest!
Anti-leukemic activity in the absence of severe toxicities with nonviral Sleeping Beauty–engineered CAR T cells. Thanks to all our great collaborators.
#Immunotherapy #tcells #GeneTherapy
https://t.co/TUttB9Q7sj

[Paul Saultier, MD, PhD @psaultier]

@aphm_actu @univamu @PrDRossi

[La Provence @laprovence]

Dans les #BouchesduRhône, seulement 20 lits restent disponibles pour les patients du #Covid19
https://t.co/bomjN6VtU6

[Nicolas Duployez @NicolasDuployez]

Novel mechanism of FLT3 activation in BCP-ALL

[Paul Saultier, MD, PhD @psaultier]

@medburnbook Hemophiliac arriving with gunshot wounds

[Paul Saultier, MD, PhD @psaultier]

How #hemoglobin complex evolved from an ancestral monomer to a modern tetramer ?
Fascinating insights into the evolution of the protein complex mediating respiratory #oxygen transport.
https://t.co/mMxsKsGbnE

[Paul Saultier, MD, PhD @psaultier]

https://t.co/yDBrdALqt3

[Paul Saultier, MD, PhD @psaultier]

Higher than anticipated frequency of germline RUNX1 mutations among patients with RUNX1-mutated acute myeloid #leukemia. This study suggest specific pathophysiology.
#predisposition @BloodJournal